Business ❯ Pharmaceuticals

Drug Companies

Pricing Strategies Suizo Argentina Contracts Corporate Ethics AstraZeneca Eli Lilly and Novo Nordisk Bristol Myers Squibb Market Performance Novartis Public Procurement Prevacus Cost Reduction Market Competition Market Influence EMD Serono Johnson & Johnson Novo Nordisk Biogen Regulatory Actions Opioid Treatments

Bristol Myers and J&J Halt Milvexian Heart-Attack Trial After Futility Finding

Two remaining Phase 3 studies in atrial fibrillation and secondary stroke prevention continue, with topline results expected in 2026.

AstraZeneca H1 Revenue Jumps 11% as It Pledges $50 Billion U.S. Expansion

Trump Vows Unachievable 1,400% Drug Price Cuts, Threatens Trade Sanctions